"Translocation, Genetic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A type of chromosome aberration characterized by CHROMOSOME BREAKAGE and transfer of the broken-off portion to another location, often to a different chromosome.
Descriptor ID |
D014178
|
MeSH Number(s) |
C23.550.210.870 G05.365.590.175.870 G05.558.860
|
Concept/Terms |
Translocation, Genetic- Translocation, Genetic
- Genetic Translocation
- Genetic Translocations
- Translocations, Genetic
- Chromosomal Translocation
- Chromosomal Translocations
- Translocations, Chromosomal
- Translocation, Chromosomal
|
Below are MeSH descriptors whose meaning is more general than "Translocation, Genetic".
Below are MeSH descriptors whose meaning is more specific than "Translocation, Genetic".
This graph shows the total number of publications written about "Translocation, Genetic" by people in this website by year, and whether "Translocation, Genetic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
2002 | 1 | 0 | 1 |
2007 | 0 | 1 | 1 |
2016 | 0 | 2 | 2 |
2019 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Translocation, Genetic" by people in Profiles.
-
Prognostic significance of copy number gains of MYC detected by fluorescence in situ hybridization in large B-cell lymphoma. Leuk Lymphoma. 2024 Jan; 65(1):26-36.
-
The evolving role of translocation t(11;14) in the biology, prognosis, and management of multiple myeloma. Blood Rev. 2020 05; 41:100643.
-
Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2. Cancer. 2019 06 01; 125(11):1830-1836.
-
C-MYC-positive relapsed and refractory, diffuse large B-cell lymphoma: Impact of additional "hits" and outcomes with subsequent therapy. Cancer. 2017 11 15; 123(22):4411-4418.
-
Dermatofibrosarcoma protuberans: pathology, genetics, and potential therapeutic strategies. Ann Diagn Pathol. 2016 Dec; 25:64-71.
-
B-cell acute lymphoblastic leukemia with mature phenotype and MLL rearrangement: report of five new cases and review of the literature. Leuk Lymphoma. 2016 10; 57(10):2289-97.
-
The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity. Blood. 2008 Jan 15; 111(2):856-64.
-
A mannosyltransferase gene at 11q23 is disrupted by a translocation breakpoint that co-segregates with bipolar affective disorder in a small family. Neurogenetics. 2002 Mar; 4(1):43-53.
-
The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP. Hum Mol Genet. 1998 Apr; 7(4):637-42.
-
X-linked pachygyria and agenesis of the corpus callosum: evidence for an X chromosome lissencephaly locus. Ann Neurol. 1994 Aug; 36(2):229-33.